Contact Us
By precisely controlling low-frequency ultrasound energy, we can interact with biological tissues through two distinct and well-characterized mechanisms: transient enhancement of barrier permeability for non-invasive molecular delivery, and direct modulation of cellular behavior via mechanotransduction. These mechanisms underpin our two proprietary technology platforms, each engineered to address significant clinical needs with improved safety and therapeutic potential.
Molecular Transport
Precision & Safety
Cellular Modulation
Spatial Targeting
Ultrasound-Mediated Drug Delivery
MeticTouch® is a proprietary ultrasound-based drug delivery platform designed to transport therapeutic molecules across biological barriers non-invasively. The platform is drug-agnostic and engineered to work seamlessly with a broad range of therapeutics without the need for reformulation.
Drug-Agnostic
Compatible with small molecules, biologics, antibodies, and gene therapies. No reformulation required.
Multiple Barriers
Validated in preclinical studies; applicable in ocular and skin delivery.
Non-Invasive
Transient and reversible interaction. No tissue damage or inflammatory responses observed in preclinical studies.
Precision Targeting
Applicable wherever a biological barrier separates a drug from its target, across multiple anatomical sites.
Ultrasound Biomechanical Cell Stimulation
MeticStim® is a therapeutic platform in which the ultrasound energy itself acts as the active agent. It is engineered to modulate the biological behavior of living cells and tissues through acoustic stimulation, requiring no pharmaceutical drugs and resulting in no systemic drug exposure.
Drug-Free
The ultrasound energy is the therapeutic agent, eliminating pharmaceutical complexity and systemic side effects.
Tissue-Safe
Acoustic stimulation is designed to modulate cellular behaviour without causing thermal or mechanical damage.
Broad Applicability
Any disease state driven by modifiable cellular behaviour represents a potential application domain.
Programmable Response
Specific parameters can be tuned to elicit precise cellular outcomes, including stimulation, inhibition, or tissue modulation.
Discover our two platforms with one unified goal: defining a new paradigm for non-invasive precision medicine.
|
|
|
| Core Function | Ultrasound-mediated drug delivery | Ultrasound biomechanical cell stimulation |
| Mode of Action | Transient permeability enhancement of biological barriers | Direct acoustic modulation of cellular behaviour |
| Regulatory Pathway | Combination product (device + drug) | Medical device |
| Development Status | Advancing into First-in-Human clinical evaluation | Preclinical & Product Realization |
| Commercial Model |
|
|